MET and breast carcinoma: To do this, we determined the expression of HGF, c-Met and CXCR4 in breast cancer tissues by immunohistochemistry using corresponding antibodies, which revealed positive immunostaining of HGF, c-Met or CXCR4 in 197 cases of invasive breast carcinoma.